Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: Gender-specific metabolic effects

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 11, 1998, Pages 3890-3896

  Kuromaru, R ^a   Kohno, H ^b   Ueyama, N ^b   Hassan, H M S ^b   Honda, S ^b   Hara, T ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY FAT; BODY MASS; FEMALE; GROWTH; GROWTH HORMONE DEFICIENCY; HEIGHT; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE;

EID: 0031763971     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.11.3890     Document Type: Article

References (52)

1. Rosen T, Bengtsson BA. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
2. Salomon F, Cuneo RC, Hesp R, Sonksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
3. Newman WP, Wattigney W, Berenson GS. 1994 Autopsy studies in United States children and adolescents: relationship of risk factors to atherosclerosis lesions. Ann NY Acad Sci. 623:16-25.
4. Lauer RM, Lee J, Clarke WR. 1988 Factors affecting the relationship between childhood and adult cholesterol levels: The Muscatine Study. Pediatrics. 82:309-318.
5. Bao W, Srinivasan SR, Wattigney WA. 1996 Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks: The Bogalusa Heart Study. Arch Intern Med. 156:1315-1320.
6. Brasel J, Wright JC, Wilkins L, Blizzard RM. 1965 An evaluation of seventy-five patients with hypopituitarism beginning in childhood. Am J Med. 38:484-498.
7. Zachmann M, Fernandez F, Tassinari D, Thakker R, Prader A. 1980 Anthropometric measurements in patients with growth hormone deficiency before treatment with human growth hormone. Eur J Pediatr. 133:277-282.
8. de Muinck Keizer-Schrama S, Rikken B, Hokken-Koelega A, Wit JM. 1994 Comparative study of two doses of growth hormone for growth hormone deficiency. Arch Dis Child. 71:12-18.
9. Tanner JM, Whitehouse RH. 1967 The effect of human growth hormone on subcutaneous fat thickness in hyposomatotrophic and panhypopituitary dwarfs. J Endocrinol. 39:263-275.
10. Novak LP, Hayles AB, Cloutier MD. 1972 Effect of HGH on body composition of hypopituitary dwarfs. Mayo Clin Proc. 47:241-246.
11. Collipp PJ, Curti V, Thomas J, Sharma RK, Maddaiah VT, Cohn SH. 1973 Body composition changes in children receiving human growth hormone. Metabolism. 22:589-595.
12. Bonnet F, Vanderschveren-Lodewyck M, Erkels R, Malraux P. 1974 Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with HGH. Pediatr Res. 81:800-805.
13. Parra A, Argote RM, Garcia G, Cervantes C, Alatorre S, Perez-Pasten E. 1979 Body composition in hypopituitary dwarfs before and during human growth hormone therapy. Metabolism. 28:851-857.
14. Winter RJ, Thompson RG, Green OC. 1979 Serum cholesterol and triglycerides in children with growth hormone deficiency. Metabolism. 28:1244-1249.
15. Blackett PR, Weech PK, McConathy WJ, Fesmire JD. 1982 Growth hormone in regulation of hyperlipidemia. Metabolism. 31:117-120.
16. White RM, Schaefer EJ, Papadopoulos NM. 1983 The effect of growth hormone administration on lipids and lipoproteins in growth hormone-deficient patients. Proc Soc Exp Biol Med. 173:63-67.
17. Heubi JE, Burstein S, Sperling MA, Gregg D, Rabi Subbiah MT, Matthews DE. 1983 The role of human growth hormone in the regulation of cholesterol and bile acid metabolism. J Clin Endocrinol Metab. 57:885-891.
18. Winter RJ, Green OC. 1984 Effect of thyroxine and growth hormone on the hypercholesterolemia of growth hormone deficiency. Metabolism. 33:54-57.
19. Asayama K, Amemiya S, Kusano S, Kato K. 1984 Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism. 33:129-131.
20. Gacs G, Romics L. 1987 Effect of growth hormone on serum lipoproteins in growth hormone deficiency. Exp Clin Endocrinol. 90:227-231.
21. Frindik JP, Kemp SF, Elders JM, Morris M. 1989 The effect of growth hormone on lipid profiles of growth hormone deficient children. J Pediatr Endocrinol. 3:167-170.
22. Rosenbaum M, Gertner JM, Leibel RL. 1989 Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab. 69:1274-1281.
23. Vaisman N, Zadik Z, Shamai Y, Franklin L, Dukhan R. 1992 Changes in body composition of patients with subnormal spontaneous secretion of growth hormone, during the first year of treatment with growth hormone. Metabolism. 41:483-486.
24. Leger J, Carel C, Legrand I, Paulsen A, Hassan M, Czernichow P. 1994 Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome, and intrauterine growth retardation during the first year of treatment with GH. J Clin Endocrinol Metab. 78:904-909.
25. Schaefer GB, Greger NG, Fesmire JD, Blackett PR, Wilson DP, Frindik JP. 1994 Lipids and apolipoproteins in growth hormone-deficient children during treatment. Metabolism. 43:1457-1461.
26. Kohno H, Ueyama N, Yanai S, Ukaji K, Honda S. 1995 Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency. J Pediatr. 126:953-955.
27. Hassan HMS, Kohno H, Kuromaru R, Honda S, Ueda K. 1996 Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment. Acta Paediatr. 85:899-901.
28. Boot AM, Engels MAMJ, Boerma GJM, Krenning EP, de Muinck Keizer SMPF. 1997 Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab. 82:2423-2428.
29. Capaldo B, Patti L, Oliviero U, et al. 1997 Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab. 82:1378-1381.
30. Suwa S, Tachibana K. 1993 Standard growth charts for height and weight of Japanese children from birth to 17 years based on a cross-sectional survey of national data. Clin Pediatr Endocrinol. 2:87-97.
31. Lukaski HC. 1987 Methods for assessment of human body composition: traditional and new. Am J Clin Nutr. 46:537-556.
32. Houtkooper L, Going SB, Iohman TG, Roche AF, Loan MV. 1992 Bioelectrical impedance estimation of fat-free body mass in children and youth: a cross-validation study. J Appl Physiol. 72:366-373.
33. Friedewald WT, Levy RI, Fredrickson DS. 1972 Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem. 18:499-502.
34. Ikeda T, Shibuya Y, Senba U, et al. 1991 Automated immunoturbidimetric analysis of six plasma apolipoproteins: correlation with radial immunodiffusion assays. J Clin Lab Anal. 5:90-95.
35. Castelli WP, Abbott RD, McNamara PM. 1983 Summary estimates of cholesterol used to predict coronary heart disease. Circulation. 67:730-734.
36. Avogaro P, Bittolo Bon G, Cazzolato G, Quinci GB. 1979 Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet. 1:901-903.
37. Abe A, Yoshimura Y, Sekine T, Maeda S, Yamashita S, Noma A. 1994 Fully mechanized latex immunoassay for serum lipoprotein(a). Clin Chim Acta. 225:105-113.
38. Noma A, Hata Y, Goto Y. 1991 Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: reference values, and age- and sex-related differences. Clin Chim Acta. 199:147-158.
39. Fukushige J, Igarashi H, Ueda K, Akazawa K, Nose Y. 1996 Serum cholesterol levels in school-aged Japanese children: the Hisayama study. Acta Paediatr Jpn. 38:22-27.
40. Sato H, Miyamoto S, Sasaki N, Niimi H. 1995 Sex and developmental variation of body composition assessed by bioelectrical impedance analysis in school children. J Jpn Pediatr Soc. 99:1405-1411.
41. Boot AM, Bouquet J, de Ridder MAJ, Krenning EP, de Muinck Keizer-Schrama SMPF. 1997 Determinants of body composition measured by dual-energy x-ray absorptiometry in Dutch children and adolescents. Am J Clin Nutr. 66:232-238.
42. Rudling M, Olivecrona H, Eggertsen G, Angelin B. 1996 Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I. J Clin Invest. 97:292-299.
43. Hassan HMS, Kohno H, Kuromaru R, Honda S, Ueda K. 1995 Lipoprotein(a) changes during growth hormone treatment. Clin Endocrinol (Oxf). 43:655.
44. Nolte W, Radisch C, Armstrong VW, Hufner M, von zur Muhlen A. 1997 The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial. Eur J Endocrinol. 137:459-466.
45. Rutherford OM, Jones DA, Round JM, Buchanan CR, Preece MA. 1991 Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin Endocrinol (Oxf). 34:469-475.
46. Colle M, Auzerie J. 1993 Discontinuation of growth hormone thrapy in growth-hormone-deficient patients: assessment of body fat mass using bioelectrical impedance. Horm Res. 39:192-196.
47. Ogle GD, Moore B, Lu PW, Craighead A, Briody JN, Cowell CT. 1994 Changes in body composition and bone density after discontinuation of growth hormone therapy in adolescence: an interim report. Acta Paediatr. 399(Suppl):3-7.
48. Libber SM, Plotnick LP, Johanson AJ, Blizzard RM, Kwiterovich PO, Migeon CJ. 1990 Long-term follow-up of hypopituitary patients treated with human growth hormone. Medicine. 69:46-55.
49. Kikkland RT, Keenan BS, Probstfield JL, et al. 1987 Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence: correlation with plasma testosterone levels. J Am Med Assoc. 257:502-507.
50. Johannsson G, Bjarnason R, Bramnert M, et al. 1996 The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab. 81:1575-1581.
51. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson A. 1997 Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than woman. J Clin Endocrinol Metab. 82:550-555.
52. Carroll PV, Christ ER, Growth Hormone Research Society Scientific Committee. 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab. 83: 382-395.